Next, we found MEF2A gene expression in advanced tumor samples was significantly higher than that in early stage tumor samples, consistent with the oncogenic role of SEC23A in bladder cancer (Figure 6F). The gene discussed is SEC23A; the disease is urinary bladder carcinoma.